Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

Medical University of Vienna

Status: Enrolling

Conditions: Uveal Melanoma

Treatments: Diagnostic Test: Clinical examination and multimodal ocular imaging

Study type: Observational

Funder types: Other

Identifiers

NCT06280040

UM Longitudinal 1942/2022

Details and patient eligibility

About

The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as 3, 6, 9 and 12 months after radiation using sonography funds photography, optical coherence tomography angiography, oximeter and microperimetry.

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with newly diagnosed uveal melanoma, who will be treated with hypofractionated stereotactic photon radiotherapy as part of clinical routine.

Exclusion criteria

• unwillingness to participate in the study
• severe media opacity

Trial design

20 participants in 1 patient group

Uveal Melanoma

Description:

Patients with newly diagnosed uveal melanoma, which will be treated with hypofractionated stereotactic photon radiotherapy as clinical routine.

Treatment:

Diagnostic Test: Clinical examination and multimodal ocular imaging